SCHEMBL9547343

SCHEMBL9547343

CCCCOC(Cl)c1cc(NC(C)=O)cc(Nc2c3ccccc3nc3ccccc23)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.53
POLB P06746 3/20 0.53
MAPT P10636 2/20 0.53
RAD52 P43351 2/20 0.53
KMT2A Q03164 2/20 0.53
NPSR1 Q6W5P4 2/20 0.53
L3MBTL1 Q9Y468 2/20 0.53
KDM1A O60341 1/20 0.53
MITF O75030 1/20 0.53
LMNA P02545 1/20 0.53
RECQL P46063 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
TOP2A P11388 7/20 0.46
TOP2B Q02880 6/20 0.46
OPRM1 P35372 1/20 0.42
OPRD1 P41143 1/20 0.42
SLC2A1 P11166 1/20 0.41
ATM Q13315 1/20 0.41
MOK Q9UQ07 1/20 0.40
GLA P06280 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9547325 0.84 TOP2A (0.50) KDM4EPOLBMAPTRAD52KMT2A
SCHEMBL9547337 0.80 KDM4E (0.55) KDM4EPOLBMAPTRAD52KMT2A
SCHEMBL9300852 0.75 KMT2A (0.72) KDM4EPOLBMAPTRAD52KMT2A
SCHEMBL9300052 0.74 TOP2A (0.73) KDM4EPOLBMAPTRAD52KMT2A
SCHEMBL9300054 0.74 TOP2A (0.74) KDM4EPOLBMAPTRAD52KMT2A
SCHEMBL9299881 0.73 TOP2A (0.59) KDM4EPOLBMAPTRAD52KMT2A
SCHEMBL17154374 0.73 KMT2A (0.76) KDM4EPOLBMAPTRAD52KMT2A
SCHEMBL9300986 0.73 POLB (0.55) KDM4EPOLBMAPTRAD52KMT2A
SCHEMBL9300667 0.72 TOP2A (0.53) KDM4EPOLBMAPTRAD52KMT2A
SCHEMBL9300496 0.72 TOP2A (0.52) KDM4EPOLBMAPTRAD52KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1993023049-A1 3-(9-ACRIDINYLAMINO)-5-HYDROXYMETHYLANILINE DERIVATIVES AS ANTICANCER AGENTS SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1993-11-25 WO claimed